Press release -

BusinessGreen publishes Insight Report on tackling livestock emissions as an innovative and rapidly expanding new market

Released on June 21, the BusinessGreen Insight Report takes a close look at all companies that are offering solutions and technologies to limit methane emitted by cattle. With more than 1.5 billion cattle on earth representing 15% of global emissions, and the Paris agreement in place, innovative solutions and a new market for agriculture technologies that reduce livestock emissions is growing rapidly. The report unveils the first comprehensive industry landscape of all the players addressing livestock emissions with new technologies that open up an entirely new industry with enormous potential.

Mootral, a technology developed by the Swiss-led life-science company Zaluvida, is mentioned as a frontrunner when it comes to delivering a climate-smart solution and a tangible, commercially scalable mechanism.

According to Zaluvida Group CEO Christoph Staeuble Mootral is much more than a livestock feed supplement, reducing methane emissions by at least 30 percent. Staeuble believes it is one of the most compelling opportunities for farmers to improve their profitability: “Farmers are already doing a lot more to reduce greenhouse gases than they are given credit for. With Mootral they could do even more whilst finally getting financial rewards for their efforts by means of higher prices for climate-friendly beef and dairy products.”

“The need to reduce livestock emissions in order to foster a healthier climate must involve and benefit all players: businesses, farmers and consumers”, said Michael Mathres, President of Zaluvida's Mootral division, “The difference between us and our competitors is that we see the commercial side as a crucial component to reach the globally agreed climate objectives.”

Topics

  • Corporate Information

Categories

  • mootral
  • english press releases

About Zaluvida

Zaluvida is a globally operating life science group that endeavors to rapidly develop solutions for the biggest challenges in healthcare. The company is led from its corporate offices in Switzerland and has branches in Germany, Wales, the Netherlands, the US and Malaysia. By making use of unique bioactive compounds with pharma-grade efficacy, Zaluvida is a pioneer in therapies and technologies for obesity, antibiotic resistance and for the reduction of greenhouse gas emissions. Our team is united by the desire to use visionary biotech innovations to support as many people as possible in shaping a better future for themselves. 

For further information visit: www.zaluvida.com

Contacts

APCO Worldwide

Press contact +49 69 260140800

Zaluvida Press Office

Press contact +41 21 822 23 62